EAM Investors’s Encompass Health EHC Stock Holding History

EAM Investors’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38,027	Closed	-$4.66M	–	287
2025 Q2	$4.66M	Buy	+38,027	New	+$4.34M	0.71%	50
2024 Q3	–	Sell	-37,808	Closed	-$3.24M	–	268
2024 Q2	$3.24M	Buy	+37,808	New	+$3.17M	0.53%	102
2019 Q1	–	Sell	-17,628	Closed	-$865K	–	272
2018 Q4	$865K	Sell	17,628 -18,385	-51%	-$1.05M	0.23%	186
2018 Q3	$2.23M	Sell	36,013 -29,542	-45%	-$1.8M	0.33%	143
2018 Q2	$3.53M	Sell	65,555 -25,741	-28%	-$1.29M	0.56%	44
2018 Q1	$4.15M	Buy	+91,296	New	+$3.91M	0.69%	21
2014 Q1	–	Sell	-38,108	Closed	-$1.01M	–	324
2013 Q4	$1.01M	Sell	38,108 -8,254	-18%	-$230K	0.18%	294
2013 Q3	$1.27M	Sell	46,362 -4,128	-8%	-$106K	0.25%	155
2013 Q2	$1.16M	Buy	+50,490	New	+$1.14M	0.25%	160

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM Investors's EHC Position: Q3 2025 in Review

EAM Investors sold out of Encompass Health (EHC) in Q3 2025, closing a stake of 38,027 shares — an estimated $4.66M sold.

EAM Investors first reported a position in EHC in Q2 2013 and held it in 9 quarters. The position peaked at $4.66M in Q2 2025. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.

EAM Investors reported no remaining Encompass Health position as of Q3 2025 after selling out during the quarter.
EAM Investors sold 38,027 Encompass Health shares in Q3 2025, an estimated $4.66M.
EAM Investors first reported a position in Encompass Health in Q2 2013 and held it in 9 quarters.
EAM Investors's Encompass Health position peaked at $4.66M in Q2 2025.
604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.

Based on EAM Investors's 13F filing for Q3 2025, filed 14 Nov 2025.